Survival Outcomes of Treatment Modalities in Patients with Variant Histopathology of Bladder Cancer in First Transurethral Resection of the Bladder
- 4 April 2024
- journal article
- research article
- Published by Galenos Yayinevi in Üroonkoloji Bülteni
- Vol. 23 (1) , 22-28
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Survival Outcomes After Immediate Radical Cystectomy Versus Conservative Management with Bacillus Calmette-Guérin Among T1 High-grade Micropapillary Bladder Cancer Patients: Results from a Multicentre CollaborationEuropean Urology Focus, 2022
- Radical cystectomy improves survival in patients with stage T1 squamous cell carcinoma and neuroendocrine carcinoma of the urinary bladderEuropean Journal of Surgical Oncology, 2021
- Bladder preserving chemoradiotherapy compared to surgery for variants of urothelial carcinoma and other tumors types involving the bladder: An analysis of the National Cancer DatabaseClinical and Translational Radiation Oncology, 2021
- European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 UpdateEuropean Urology, 2019
- Clinical Outcomes of Patients with Histologic Variants of Urothelial Cancer Treated with Trimodality Bladder-sparing TherapyEuropean Urology, 2017
- The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs—Part B: Prostate and Bladder TumoursEuropean Urology, 2016
- Clinicopathological characteristics of urothelial bladder cancer in patients less than 40 years oldVirchows Archiv, 2015
- Incidence, survival and mortality rates of stage-specific bladder cancer in United States: A trend analysisCancer Epidemiology, 2013
- Defining Early Morbidity of Radical Cystectomy for Patients with Bladder Cancer Using a Standardized Reporting MethodologyEuropean Urology, 2009
- Micropapillary bladder cancerCancer, 2007